Alpha Centric Advisors LLC Danaher Corp Transaction History

Alpha Centric Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$292.08 - $329.01 $76,524 - $86,200	-262 Closed	0 $0
Q3 2021 Mar 09, 2022	SELL	$272.21 - $332.43 $272 - $332	-1 Reduced 0.38%	262 $80,000
Q2 2021 Mar 09, 2022	BUY	$225.08 - $271.69 $7,427 - $8,965	33 Added 14.35%	263 $71,000
Q1 2021 Mar 09, 2022	SELL	$212.38 - $245.9 $1,699 - $1,967	-8 Reduced 3.36%	230 $52,000
Q4 2020 Mar 11, 2022	BUY	$212.5 - $245.46 $50,575 - $58,419	238 New	238 $53,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.